Pharmacology, Toxicology and Pharmaceutical Science
Ovary Cancer
93%
Malignant Neoplasm
93%
Aptamer
68%
Neoplasm
64%
Diseases
40%
Combination Therapy
40%
Mouse Model
37%
Polychlorinated Biphenyl
37%
microRNA
37%
Endometrium Cancer
37%
Untranslated RNA
36%
Carcinogenesis
32%
Protein Tyrosine Kinase
30%
Tumor Growth
26%
Long Untranslated RNA
24%
Breast Cancer
23%
Dioxins and Dioxin-Like Compounds
22%
Protein Kinase B
22%
Receptor
21%
Drug Resistance
21%
Cancer Model
20%
Leptin
18%
Selinexor
18%
Antisense Oligodeoxynucleotide
18%
Immunomodulation
18%
Olaparib
18%
Endocrine Therapy
18%
Microbiome
18%
Uterus Cancer
18%
Therapy Resistance
18%
Growth Factor Receptor Bound Protein 2
18%
Lactobacillus paracasei
18%
Digestive System Cancer
18%
Tamoxifen
18%
Colorectal Carcinoma
18%
Antisense Oligonucleotide
18%
SARS Coronavirus
18%
Biological Marker
15%
Metastasis
12%
Nanoparticle
11%
Cell Viability
9%
Ephrin
9%
Ephrin Receptor
9%
Microorganism
8%
Small Interfering RNA
7%
Paclitaxel
7%
Panobinostat
7%
Chemotherapy
7%
Egg Lecithin
6%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
6%
Keyphrases
Ovarian Cancer
100%
Non-coding RNA (ncRNA)
90%
Endometrial Cancer
37%
Long Non-coding RNA (LncRNA)
37%
Aptamer
33%
Therapeutic Target
33%
Chemotherapy
28%
In Cancer
26%
Ovarian Cancer Cells
25%
Tumor Growth
24%
Mouse Model
21%
Receptor Tyrosine Kinase
21%
Cancer Treatment
21%
Cancer Model
20%
Cancer Gene Therapy
18%
Explainable Artificial Intelligence
18%
Adaptive Resistance
18%
Potential Therapeutics
18%
Therapeutic Approaches
18%
Ku70
18%
Inhibit Tumor
18%
Peritoneal Metastasis
18%
Liposomal
18%
Antisense Oligonucleotides
18%
Cell Line Models
18%
Cancer Advancement
18%
Ku80
18%
PRKAR1B
18%
Immune Regulation
18%
Immune Response
18%
Insulin-like Growth Factor 2 mRNA-binding Protein 2 (IGF2BP2)
18%
RNA Delivery
18%
Rational Combinations
18%
MicroRNA
18%
Olaparib
18%
DNA Repair
18%
Targeted Combination Therapy
18%
Therapeutic Efficacy
18%
Gut Microbiome
18%
Interfering Ligands
18%
Back to the Future
18%
Anti-vascular Endothelial Growth Factor Therapy
18%
Tumor Microenvironment
18%
AXL Receptor
18%
CRM1 Inhibitor
18%
Functional Spectrum
18%
Endocrine Resistance
18%
FLANC
18%
CDK7
18%
PCB 180
18%
Medicine and Dentistry
Ovarian Cancer
93%
Malignant Neoplasm
63%
Uterine Cancer
56%
Aptamer
56%
Combination Therapy
42%
Tumor Microenvironment
37%
Tumor Progression
36%
Drug Resistance
33%
Protein Tyrosine Kinase
27%
Long Untranslated RNA
24%
In Vitro
23%
Carcinogenesis
23%
Untranslated RNA
23%
Protein Kinase B
22%
Neoplasm
21%
Metastatic Carcinoma
20%
Cancer Model
20%
Breast Cancer
18%
microRNA
18%
Wee1
18%
Immunomodulation
18%
Exosome
18%
Chemotherapy
18%
Gut Microbiome
18%
Vasculotropin
18%
Antisense Oligodeoxynucleotide
18%
Growth Factor Receptor Bound Protein 2
18%
Gastrointestinal Cancer
18%
Synbiotic
18%
Lactobacillus paracasei
18%
Antiangiogenic Therapy
18%
Targeted Therapy
18%
Neuro-Oncology
18%
Oncology
18%
Antisense Oligonucleotide
18%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Cancer
17%
RNA Sequence
14%
Diseases
13%
Cancer Cell
12%
Cancer Therapy
10%
Programmed Cell Death
9%
Cell Communication
9%
Immunocompetent Cell
9%
The Cancer Genome Atlas
8%
Overall Survival
8%
Metabolite
7%
Paclitaxel
7%
Panobinostat
7%
Treatment Response
7%